Estimates Revisions Aptevo Therapeutics Inc. Nasdaq
Stocks
APVO
US03835L5049
Biotechnology & Medical Research
|
Delayed
Nasdaq
23:00:00 01/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 1.760 USD | -3.30% |
|
-3.83% | -81.34% |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
Aptevo Therapeutics Inc.(APVO)
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
- Stock Market
- Stocks
- APVO Stock
- APVO Stock
- Consensus Aptevo Therapeutics Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
